Healthcare
Based on ARK ETF real-time + 13F quarterly filings
13F data may be delayed up to 90 days.
※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.
Pacific Biosciences of California (PACB) designs, develops, and manufactures advanced sequencing solutions, primarily their SMRT technology and instruments like Revio and Sequel, to address complex genetic challenges. They offer a comprehensive suite of systems, consumables, and reagent kits for various applications. PACB serves a broad range of research and clinical institutions, including pharmaceutical, agricultural, and public health organizations, positioning itself as a key player in the genomics field.
AI-generated summary. Not investment advice.